thymoquinone has been researched along with Cancer of Liver in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 10 (62.50) | 2.80 |
| Authors | Studies |
|---|---|
| Abualnaja, KO; Al-Babili, S; Al-Malki, AL; Alhosin, M; Asami, T; Choudhry, H; Halwani, MA; Hasan, MN; Kumosani, TA; Moselhy, SS; Omran, Z; Razvi, SS; Zamzami, MA | 1 |
| Badary, OA; Fahim, SA; Ibrahim, S; Tadros, SA | 1 |
| Abdualmjid, RJ; Sergi, CM | 1 |
| Abdelwahed, FM; Attia, YM; Badary, OA; Fahim, SA; Ibrahim, S; Maurice, NW; Tadros, SA | 1 |
| Babalghith, AO; El-Far, AH; El-Sewedy, T; El-Shehawy, AA; Elmetwalli, A; Gaber, M; Mahmoud, MA; Mohany, H; Mosallam, SAE; Salama, AF | 1 |
| Abd-Elaziz, A; Khalil, H; Salah, A; Sleem, R | 1 |
| Afşar, E; Aslan, M; Çeker, T; Kırımlıoglu, E; Yılmaz, Ç | 1 |
| Anwer, R; Bashir, AO; Eissa, LA; El-Mesery, ME | 1 |
| Liu, M; Wu, T; Xi, M; Xu, G; Yu, J; Zhang, R; Zheng, P | 1 |
| Gao, J; Huang, CY; Kang, ZF; Ting, WJ; Weng, YJ; Zhang, B | 1 |
| Kapoor, VK; Malik, S; Negi, P; Singh, A | 1 |
| Bardakci, O; Gozeneli, O; Guldur, ME; Gunes, AE; Taskin, A; Tatli, F; Yilmaz, M | 1 |
| Ebeid, EM; El-Ashmawy, NE; Khedr, EG; Mosalam, EM; Salem, ML; Zidan, AA | 1 |
| Abd-Allah, AR; Abdel-Hamied, HE; Alzahrani, AZ; Ashour, AE; Attia, SM; Bakheet, SA; Jamal, S; Korashy, HM; Rishi, AK; Saquib, Q | 1 |
| Abdelaziz, A; Ashmawy, AM; Badary, O; ElKhoely, A; Hafez, HF; Mostafa, A; Shouman, SA | 1 |
| Cheng, Y; He, S; Ke, X; Liu, Y; Lu, G; Lu, X; Meltzer, SJ; Ren, M; Song, JH; Sun, Z; Wang, Z; Xu, Z; Zhang, D; Zhao, Y | 1 |
2 review(s) available for thymoquinone and Cancer of Liver
| Article | Year |
|---|---|
Mitochondrial Dysfunction and Induction of Apoptosis in Hepatocellular Carcinoma and Cholangiocarcinoma Cell Lines by Thymoquinone.
Topics: Animals; Apoptosis; Benzoquinones; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cell Line, Tumor; Cholangiocarcinoma; Liver Neoplasms; Mitochondria | 2022 |
Thymoquinone: A small molecule from nature with high therapeutic potential.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Antioxidants; Benzoquinones; Biological Availability; Breast Neoplasms; Carcinoma, Hepatocellular; Cardiomyopathies; Colonic Neoplasms; Diabetes Mellitus, Type 2; Humans; Liver Neoplasms; Nanoparticle Drug Delivery System; Neoplasms; Nervous System Diseases | 2021 |
14 other study(ies) available for thymoquinone and Cancer of Liver
| Article | Year |
|---|---|
Synthetic strigolactone analogues reveal anti-cancer activities on hepatocellular carcinoma cells.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Hep G2 Cells; Humans; Lactones; Liver Neoplasms; Molecular Structure; Structure-Activity Relationship | 2018 |
Suppressive effects of thymoquinone on the initiation stage of diethylnitrosamine hepatocarcinogenesis in rats.
Topics: Animals; Antioxidants; Benzoquinones; Carcinoma, Hepatocellular; Diethylnitrosamine; Glutathione; Liver; Liver Neoplasms; Male; Oxidative Stress; Rats; Rats, Wistar | 2022 |
Thymoquinone Suppresses Angiogenesis in DEN-Induced Hepatocellular Carcinoma by Targeting miR-1-3p.
Topics: Animals; Carcinoma, Hepatocellular; Gene Expression Regulation, Neoplastic; Liver Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; MicroRNAs; Rats; Vascular Endothelial Growth Factor A | 2022 |
Thymoquinone, piperine, and sorafenib combinations attenuate liver and breast cancers progression: epigenetic and molecular docking approaches.
Topics: Epigenesis, Genetic; Humans; Liver Neoplasms; MicroRNAs; Molecular Docking Simulation; Sorafenib | 2023 |
Regulation of NF-κB Expression by Thymoquinone; A Role in Regulating Pro-Inflammatory Cytokines and Programmed Cell Death in Hepatic Cancer Cells.
Topics: Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Cell Line; Cytokines; GTPase-Activating Proteins; Humans; Liver Neoplasms; NF-kappa B; Tumor Suppressor Proteins | 2023 |
Antiproliferative Effects of Thymoquinone in MCF-7 Breast and HepG2 Liver Cancer Cells: Possible Role of Ceramide and ER Stress.
Topics: Apoptosis; Benzoquinones; Ceramides; Chromatography, Liquid; Endoplasmic Reticulum Chaperone BiP; Humans; Liver Neoplasms; MCF-7 Cells; Tandem Mass Spectrometry | 2021 |
Thymoquinone potentiates miR-16 and miR-375 expressions in hepatocellular carcinoma.
Topics: Apoptosis; Benzoquinones; Carcinoma, Hepatocellular; Case-Control Studies; Caspase 3; Cell Line, Tumor; Doxorubicin; Female; Humans; Liver Cirrhosis; Liver Neoplasms; Male; MicroRNAs; Middle Aged; Proto-Oncogene Proteins c-bcl-2 | 2020 |
Thymoquinone sensitizes human hepatocarcinoma cells to TRAIL-induced apoptosis via oxidative DNA damage.
Topics: Apoptosis; Benzoquinones; Carcinoma, Hepatocellular; DNA; DNA Damage; Hep G2 Cells; Humans; Liver Neoplasms; Oxidative Stress; TNF-Related Apoptosis-Inducing Ligand | 2021 |
Erk phosphorylation reduces the thymoquinone toxicity in human hepatocarcinoma.
Topics: Animals; Apoptosis; Benzoquinones; Carcinoma, Hepatocellular; Cell Line, Tumor; Extracellular Signal-Regulated MAP Kinases; Humans; Liver Neoplasms; Mice; Mice, Nude; Phosphorylation | 2021 |
Effects of thymoquinone and curcumin on the regeneration of rat livers subject to 70% hepatectomy.
Topics: Animals; Antineoplastic Agents; Antioxidants; Arginase; Benzoquinones; Biomarkers; Cell Proliferation; Ceruloplasmin; Curcumin; Female; Hepatectomy; Ki-67 Antigen; Liver; Liver Neoplasms; Liver Regeneration; Liver Transplantation; Nitric Oxide; Rats; Rats, Wistar; Tissue Plasminogen Activator | 2018 |
Loading of doxorubicin and thymoquinone with F2 gel nanofibers improves the antitumor activity and ameliorates doxorubicin-associated nephrotoxicity.
Topics: Acetylglucosamine; Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Benzoquinones; Biomarkers; Caspase 3; Cell Survival; Doxorubicin; Drug Delivery Systems; Female; Hep G2 Cells; Humans; Kidney; Liver Neoplasms; MCF-7 Cells; Mice; Nanofibers; Neoplasms, Experimental; Oxidative Stress; Particle Size | 2018 |
Thymoquinone suppression of the human hepatocellular carcinoma cell growth involves inhibition of IL-8 expression, elevated levels of TRAIL receptors, oxidative stress and apoptosis.
Topics: Apoptosis; bcl-X Protein; Benzoquinones; Carcinoma, Hepatocellular; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Proliferation; G2 Phase Cell Cycle Checkpoints; Hep G2 Cells; Humans; Interleukin-8; Liver Neoplasms; M Phase Cell Cycle Checkpoints; NF-kappa B; Oxidative Stress; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Receptors, TNF-Related Apoptosis-Inducing Ligand | 2014 |
Chemopreventive and therapeutic potentials of thymoquinone in HepG2 cells: mechanistic perspectives.
Topics: Anticarcinogenic Agents; Antineoplastic Agents; Apoptosis; Benzoquinones; Cell Cycle; Cell Line, Tumor; Cell Survival; Chemoprevention; Cytochrome P-450 CYP1A1; Drug Screening Assays, Antitumor; Glutathione; Glutathione Transferase; HCT116 Cells; HeLa Cells; Hep G2 Cells; Humans; Inhibitory Concentration 50; Liver Neoplasms; Vascular Endothelial Growth Factor A | 2015 |
TQ inhibits hepatocellular carcinoma growth in vitro and in vivo via repression of Notch signaling.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Benzoquinones; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Proliferation; Dose-Response Relationship, Drug; Down-Regulation; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Receptor, Notch1; Signal Transduction; Time Factors; Transfection; Tumor Burden; Xenograft Model Antitumor Assays | 2015 |